Bladder Cancer Clinical Trials in Erlangen
2 recruitingErlangen, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Non-muscle Invasive Bladder Cancer With Carcinoma in SituSuperficial Bladder Cancer
enGene, Inc.350 enrolled100 locationsNCT04752722
Recruiting
Not Applicable
Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined With Hyperthermia
Bladder Cancer
University of Erlangen-Nürnberg Medical School1,000 enrolled1 locationNCT05397262